CLCF1 and central nervous system cancer: In our study, CLCF1 not only showed more accurate and broader prognostic predictive ability than other IL6 family members in the gliomas data cohort (Supplementary Tables S7, S8) but also had better sensitivity to anti-PD-L1 treatment than other family members (Supplementary Table S9).